Assignee
DNX BIOTECH LLC
US·0 granted patents·2 pending applications·0 citations·filing 2017–2017
Top patents by PatentIndex Score
2 records- 0140US2018066049A1Increasing the half-life of a full-length or a functional fragment of variant anti-human TNF-alpha antibodyDNX BIOTECH LLC·Filed 2017·Application pending·0 cites
- 0239US2018028612A1Compositions and methods of using a soluble TNF-alpha receptor modified for increased half-lifeDNX BIOTECH LLC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DNX BIOTECH LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →